The right treatment depends on medical history, safety, FDA approval status, access, tolerance, side effects, muscle-preservation needs, metabolic risk, and long-term planning
The initial four weeks at 2.5mg are about building tolerance, not pushing boundaries
Most patients experience minimal to no adverse effects
Among participants in those trials who had been taking semaglutide or tirzepatide, the study found a mean weight regain of 9.69 kg (95% CI 5.7813.60) over the follow-up period (Berg et al., 2025)
However, utilizing antioxidants has been shown to change the effectiveness of treatment and, in some cases, even speed up the development of tumors
Prop 65 Warning Please note: This product is not returnable.